Those with genuine needle phobia, which affects an estimated 20 to 25 percent of adults to some degree, may find the oral route more sustainable for long-term treatment
Both are prohibited by WADA (Class S2) for athletic use, and TB-500 is detectable in doping control [10]
No large human safety trial exists
Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) AOD-9604 is a modified C-terminal fragment (residues 176191, Tyr-hGH177-191) of human growth hormone, studied for lipolytic and anti-obesity properties
Given that you are applying this compound to your scalp repeatedly over months, source selection matters for both safety and efficacy